Shanghai - Delayed Quote CNY
North China Pharmaceutical Company.Ltd (600812.SS)
5.95
0.00
(0.00%)
At close: 3:00:02 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Li Xin Wang | Chairman of the Board of Directors & GM | -- | -- | 1972 |
| Mr. Zhang Min | Deputy General Manager | -- | -- | 1971 |
North China Pharmaceutical Company.Ltd
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
North China Pharmaceutical Company.Ltd engages in the research and development, production, and sales of pharmaceutical products in China. The company primarily offers anti-infective drugs; biotechnology drugs; cardiovascular cerebrovascular; immunomodulators; and vitamins and health products. It also provides chemical pharmaceuticals, biological agricultural and veterinary drugs. North China Pharmaceutical Company.Ltd was founded in 1992 and is based in Shijiazhuang, China.
Corporate Governance
North China Pharmaceutical Company.Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
July 18, 2024 at 12:00 AM UTC
Ex-Dividend Date
Related Tickers
WSG.SG China Traditional Chinese Medicine Holdings Co Ltd
0.2300
0.00%
WSG.BE China Traditional Chinese Medicine Holdings Co Ltd
0.2400
-2.44%
DEVA.IS Deva Holding A.S.
59.15
-1.33%
CHIZF China Traditional Chinese Medicine Holdings Co. Limited
0.3360
0.00%
WUHN Wuhan General Group (China), Inc.
0.0001
0.00%
HKMPY Hikma Pharmaceuticals PLC
53.08
0.00%
CPHI China Pharma Holdings, Inc.
2.2335
+6.36%